TABLE 4.
Analysis of predictors of progression-free survival (PFS) and overall survival (OS) after recurrence
Variable | N | PFS
|
OS
|
||||
---|---|---|---|---|---|---|---|
Events | 5-year PFS Probability | P value | Events | 5-year OS Probability | P value | ||
Age at recurrence | |||||||
> 50 years | 25 | 21 | 0.17 | 0.41 | 8 | 0.58 | 0.30 |
≤ 50 years | 14 | 9 | 0.24 | 3 | 0.75 | ||
CA-125 level at recurrence | |||||||
> 35 U/ml | 21 | 16 | 0.16 | 0.72 | 6 | 0.62 | 0.70 |
≤ 35 U/ml | 10 | 6 | N/A | 2 | N/A | ||
Optimal resection of recurrent tumor | |||||||
Yes | 19 | 14 | 0.25 | 0.028 | 4 | 0.78 | 0.044 |
No | 20 | 16 | 0.12 | 7 | 0.46 | ||
Number of recurrent lesion | |||||||
Multiple | 28 | 23 | 0.05 | 0.008 | 10 | 0.51 | 0.063 |
Single | 11 | 7 | 0.58 | 1 | 0.88 | ||
SUVmax | |||||||
> 10 g/ml | 5 | 4 | 0.27 | 0.71 | 1 | 0.50 | 0.84 |
≤ 10 g/ml | 14 | 8 | N/A | 4 | N/A | ||
Total lesion glycolysis value | |||||||
> 67.7 | 5 | 4 | 0.00 | 0.099 | 2 | N/A | 0.02 |
≤ 67.7 | 11 | 6 | 0.43 | 2 | 0.67 |
N/A, not assessable.